Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001916048-26-000014

Chief Commercial Officer sold 7,438 shares at $28.12 ($209,136)

  • Chief Commercial Officer acquired 7,438 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Warren Eric · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-21 Exercise or conversion : show line 1 in the form 10b5-1 +7,438 $13.24 $98,479 45,838 D
2026-09-21 Sale : show line 2 in the form 10b5-1 −7,438 $28.12 $209,136 38,400 D
Open-market sales · 7,438 sh · avg $28.12 · $209,136

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-21 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option −7,438 230,563 D
Loading xslF345X06/wk-form4_1790117313.xml…